Bladder Cancer News

CORE-008 Cohort B Evaluates Cretostimogene in BCG-Exposed Non-Muscle Invasive Bladder Cancer - Trinity Bivalacqua - UroToday

CORE-008 Cohort B Evaluates Cretostimogene in BCG-Exposed Non-Muscle Invasive Bladder Cancer - Trinity Bivalacqua UroToday

Jonathan Anker, MD, highlights response-guided bladder preservation strategy in MIBC - Urology Times

Jonathan Anker, MD, highlights response-guided bladder preservation strategy in MIBC Urology Times

American Cancer Society Grant to Fund Research on Urinary Tract Cancer Therapies - WCM Newsroom

American Cancer Society Grant to Fund Research on Urinary Tract Cancer Therapies WCM Newsroom

Clinical Practice Updates: Navigating the New Standard of Care in Bladder Cancer - Oncology Nursing News

Clinical Practice Updates: Navigating the New Standard of Care in Bladder Cancer Oncology Nursing News

enGene Rebrands as enGene Therapeutics Ahead of Planned Bladder Cancer Gene Therapy Filing - TipRanks

enGene Rebrands as enGene Therapeutics Ahead of Planned Bladder Cancer Gene Therapy Filing TipRanks

INLEXZO™ (gemcitabine intravesical system) Assigned Permanent Billing Code, Supporting Access for Patients with Certain Bladder Cancers - Johnson & Johnson

INLEXZO™ (gemcitabine intravesical system) Assigned Permanent Billing Code, Supporting Access for Patients with Certain Bladder Cancers Johnson & Johnson

Expanding Options for Cisplatin-Ineligible Bladder Cancer - Targeted Oncology

Expanding Options for Cisplatin-Ineligible Bladder Cancer Targeted Oncology

Alan Davies reveals key symptom that led to bladder cancer diagnosis - The Independent

Alan Davies reveals key symptom that led to bladder cancer diagnosis The Independent

Tumor “Waste” Metabolite Succinate Rewires Bladder Muscle to Build Metastatic Blood-Vessel Niches | Newswise - Newswise

Tumor “Waste” Metabolite Succinate Rewires Bladder Muscle to Build Metastatic Blood-Vessel Niches | Newswise Newswise

Optimizing treatment with intravesical drug-releasing systems in NMIBC - Urology Times

Optimizing treatment with intravesical drug-releasing systems in NMIBC Urology Times

Study finds link between colorblindness and death from bladder cancer - Stanford Medicine

Study finds link between colorblindness and death from bladder cancer Stanford Medicine

Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery - Fox Chase Cancer Center

Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery Fox Chase Cancer Center

Yale Launches Innovative Clinical Trial for Metastatic Bladder Cancer - Yale School of Medicine

Yale Launches Innovative Clinical Trial for Metastatic Bladder Cancer Yale School of Medicine

Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms - ASCO Publications

Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms ASCO Publications

ImmunityBio responds to FDA scrutiny over Anktiva promotional claims with new protocols - Fierce Pharma

ImmunityBio responds to FDA scrutiny over Anktiva promotional claims with new protocols Fierce Pharma

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer - NEJM

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer NEJM

New drug developed at UC Davis offers hope to bladder cancer patients - University of California - Davis Health

New drug developed at UC Davis offers hope to bladder cancer patients University of California - Davis Health

Bladder Preservation After Neoadjuvant EV+Pembrolizumab - Bogdana Schmidt & Fernando Maluf - UroToday

Bladder Preservation After Neoadjuvant EV+Pembrolizumab - Bogdana Schmidt & Fernando Maluf UroToday

Alexandra Drakaki, MD, on misdiagnosis of bladder cancer in women - Urology Times

Alexandra Drakaki, MD, on misdiagnosis of bladder cancer in women Urology Times

FDA issues warning letter to ImmunityBio over misleading promotion of NAI - Urology Times

FDA issues warning letter to ImmunityBio over misleading promotion of NAI Urology Times

A Two-Decade Journey of Buschke-Löwenstein Tumor Without Malignant Transformation: Clinical Insights and Management - Cureus

A Two-Decade Journey of Buschke-Löwenstein Tumor Without Malignant Transformation: Clinical Insights and Management Cureus

Can ctDNA Predict Metastatic Risk in Bladder Cancer? - Oncology News Central

Can ctDNA Predict Metastatic Risk in Bladder Cancer? Oncology News Central

Hypoxia-inducible factor 1α exerts dual roles in bladder cancer progression through TIMP3-mediated regulation of angiogenesis and invasion | Scientific Reports - Nature

Hypoxia-inducible factor 1α exerts dual roles in bladder cancer progression through TIMP3-mediated regulation of angiogenesis and invasion | Scientific Reports Nature

Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients - Memorial Sloan Kettering Cancer Center

Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients Memorial Sloan Kettering Cancer Center

Advances in the management of localized bladder cancers - Nature

Advances in the management of localized bladder cancers Nature

USC study suggests type 1 diabetes may significantly raise bladder cancer risk - Keck School of Medicine of USC

USC study suggests type 1 diabetes may significantly raise bladder cancer risk Keck School of Medicine of USC

New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations - ImmunityBio

New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations ImmunityBio

New target found to improve bladder cancer treatment - Drug Target Review

New target found to improve bladder cancer treatment Drug Target Review

A multi-modal approach for decision making in bladder cancer - Nature

A multi-modal approach for decision making in bladder cancer Nature

Mayo Clinic expert highlights improved survival in muscle-invasive bladder cancer and kidney cancer - Mayo Clinic News Network

Mayo Clinic expert highlights improved survival in muscle-invasive bladder cancer and kidney cancer Mayo Clinic News Network

Artificial intelligence-assisted diagnosis and histopathological grading of bladder cancer: current status, challenges, and future directions - Frontiers

Artificial intelligence-assisted diagnosis and histopathological grading of bladder cancer: current status, challenges, and future directions Frontiers